IN VITRO AND IN VIVO EFFECT OF AN ORAL IRON CHELATOR DEFERASIROX IN MYELOID LEUKEMIA CELLS

被引：0
|
作者：
Choi, C. W. [1 ]
Kim, J. L. [2 ]
Kang, H. N. [2 ]
Kang, M. H. [2 ]
Yoo, Y. A. [2 ]
机构：
[1] Korea Univ, Guru Teg Bahadur Hosp, Seoul, South Korea
[2] Korea Univ, Coll Med, Grad Sch Med, Seoul 136705, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0639
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [1] The Oral Iron Chelator Deferasirox Induces Apoptosis in Myeloid Leukemia Cells by Targeting Caspase
    Kim, Jung-Lim
    Kang, Han-Na
    Kang, Myoung Hee
    Yoo, Young A.
    Kim, Jun Suk
    Choi, Chul Won
    ACTA HAEMATOLOGICA, 2011, 126 (04) : 241 - 245
  • [2] The oral iron chelator, deferasirox, induces apoptosis in myeloid leukemia cells through caspase-dependent activation
    Kim, Jung-Lim
    Kang, Han-Na
    Kang, Myoung Hee
    Kim, Jun Suk
    Oh, Sang-Cheul
    Choi, Chul-Won
    Yoo, Young-A
    CANCER RESEARCH, 2011, 71
  • [3] Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
    Kim, Dae Sik
    Na, Yoo Jin
    Kang, Myoung Hee
    Yoon, Soo-Young
    Choi, Chul Won
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (02): : 357 - 366
  • [4] The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
    Ohyashiki, Junko H.
    Kobayashi, Chiaki
    Hamamura, Ryoko
    Okabe, Seiichi
    Tauchi, Tetsuzo
    Ohyashiki, Kazuma
    CANCER SCIENCE, 2009, 100 (05) : 970 - 977
  • [5] The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
    Ohyashiki, J.
    Okabe, S.
    Tauchi, T.
    Ohyashiki, K.
    LEUKEMIA RESEARCH, 2009, 33 : S44 - S44
  • [6] Deferasirox: The new oral iron chelator
    Dubey, A. P.
    Sudha, S.
    Parakh, Ankit
    INDIAN PEDIATRICS, 2007, 44 (08) : 603 - 607
  • [7] Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
    Hirofumi Harima
    Seiji Kaino
    Taro Takami
    Shuhei Shinoda
    Toshihiko Matsumoto
    Koichi Fujisawa
    Naoki Yamamoto
    Takahiro Yamasaki
    Isao Sakaida
    BMC Cancer, 16
  • [8] Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
    Harima, Hirofumi
    Kaino, Seiji
    Takami, Taro
    Shinoda, Shuhei
    Matsumoto, Toshihiko
    Fujisawa, Koichi
    Yamamoto, Naoki
    Yamasaki, Takahiro
    Sakaida, Isao
    BMC CANCER, 2016, 16
  • [9] Deferasirox, an oral chelator in the treatment of iron overload
    Portioli, I.
    ITALIAN JOURNAL OF MEDICINE, 2007, 1 (04) : 35 - 40
  • [10] Deferasirox, a Newly Developed Oral Iron Chelator, Showing Antiproliferative Activity Against Pancreatic Cancer In Vitro and In Vivo
    Harima, Hirofumi
    Kaino, Seiji
    Shinoda, Shuhei
    Matsumoto, Toshihiko
    Fujisawa, Koichi
    Takami, Taro
    Yamamoto, Naoki
    Yamasaki, Takahiro
    Sakaida, Isao
    GASTROENTEROLOGY, 2016, 150 (04) : S329 - S330
12345